熱門資訊> 正文
2019-05-23 03:52
北京時間2019年05月23日03時52分,Ait Therapeutics Inc(AITB.us)股票出現異動,股價大幅下跌7.12%。截至發稿,該股報4.83美元/股,成交量1.1824萬股,換手率0.14%,振幅7.12%。
最新的2018-12-31數據顯示,該股實現營業收入0.00美元,淨利潤957581.00美元,每股收益0.11美元,毛利-18222.00美元,市盈率0.00倍。
機構評級方面,目前暫無機構對該股做出「買入、持有、賣出」建議。
Ait Therapeutics Inc股票所在的綜合服務行業中,整體跌幅為1.49%。其相關個股中,Ocean Bio-Chem Inc、Acamar Partners Acquisition Corp、Lf Capital Acquisition Corp漲幅較大,Thunder Bridge Acquisition Ltd、Pivotal Acquisition Corp、Hennessy Capital Acquisition Corp Iv較為活躍,換手率分別為3.42%、2.36%、2.04%,振幅較大的相關個股有Xynomic Pharmaceuticals Holdings Inc、Alta Mesa Resources Inc、Datasea Inc,振幅分別為11.63%、11.15%、9.23%。
Ait Therapeutics Inc公司簡介:AIT Therapeutics Inc is engaged in the healthcare market. In the development phase of the company, it is planning to develop real-time software as a service (SaaS)-based enterprise software application to manage the integration, planning, tracking and management of healthcare assets, which include people, supplies, clinical data, relationships and financial resources of healthcare organizations. The company seeks to develop healthcare enterprise software to be sold to hospitals, medical centers, and healthcare facilities worldwide.
(以上內容為自選股智能機器寫手Money Call完成,僅作為用户看盤參考,不作為交易依據。)